Influenza and COVID-19 with Michael Ison, MD, MS
As flu season begins and COVID-19 continues to spread, Michael Ison, MD, is here to share some of his latest findings. He is part of Northwestern research teams running studies both on COVID-19 and on influenza vaccines and treatments.
- Professor of Medicine in the Division of Infectious Diseases
- Professor of Surgery in the Division of Organ Transplantation
- Member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
While the COVID-19 pandemic continues, influenza season is just beginning in the United States. There is growing concern that an increase in clinic visits and hospitalizations due to the flu or COVID-19 could overwhelm healthcare systems in the months ahead, but there are things people can do to help prevent this scenario, says Michael Ison, MD, MS. Getting a flu shot and continuing to wear a mask in public and to practice social distancing and good hand hygiene are all ways to help protect yourself and others this fall and winter, he says.
Over the past 200-plus days, Ison has been devoting much of his time and expertise to understanding COVID-19 and to advancing new treatments. He is involved in clinical drug trials for COVID-19 and the use of convalescent plasma as a potentially beneficial therapeutic for the disease. He is also the chair of the Data Safety Monitoring Board for National Institute of Health trials, which included the study that led to the FDA's emergency use authorization of the drug remdesivir in COVID-19 patients.
Some of the topics covered in this episode include:
- How Northwestern Medicine scientists and physicians have been involved in COVID-19 care, experimental treatments and other related studies over the past seven months.
- Insight on President Donald Trump's diagnosis of COVID-19 and treatment strategy.
- How Ison adapted a current project studying influenza to instead collect blood samples from patients with COVID-19.
Recorded October 5, 2020.
Continuing Medical Education Credit
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
Academic/Research, Multiple specialties
At the conclusion of this activity, participants will be able to:
- Identify the research interests and initiatives of Feinberg faculty.
- Discuss new updates in clinical and translational research.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this Enduring Material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Michael Ison, MD, MS, has disclosed financial relationships with UpToDate and Shionogi. Course director, Robert Rosa, MD, has nothing to disclose. Planning committee member, Erin Spain, has nothing to disclose. Feinberg School of Medicine's CME Leadership and Staff have nothing to disclose: Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Manager of CME, Jennifer Banys, Senior Program Administrator, Allison McCollum, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.